According to the latest release from Arena Pharmaceuticals, its prescription weight loss drug, Belviq, has been released this week. This has brought the launch to almost a year after the… Read more »
Acomplia (Rimonabant) is a diet drug that works to block CB1 receptors in the endocannabinoid system of the brain, digestive system, fat tissue, muscles and liver. The endocannabinoid system has… Read more »
Qsymia, one of the newest prescription diet drugs to receive FDA approval – which its manufacturer, Vivus, obtained in mid 2012 – has just been found to have additional benefits,… Read more »
Belviq or lorcaserin, is produced and distributed by Arena Pharmaceuticals. It was designed to aid weight loss by activating receptors that trigger the release of serotonin, a chemical in the… Read more »
The Food and Drug Administration (FDA) has attempted with little success to rid the market of illegal and potentially harmful asian diet pills. These diet pills have led to the… Read more »
With nearly 350 million people being affected by diabetes, scientists are busy trying to find alternative treatments and medications to replace older diabetes medications to keep up with the rising… Read more »
The United States Food and Drug Administration has recently approved a new prescription diet drug called Qsymia. Qsymia contains a combination of phentermine (appetite suppressant) and topiramate (anticonvulsant) and is… Read more »